DE69729156D1 - Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA) - Google Patents

Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA)

Info

Publication number
DE69729156D1
DE69729156D1 DE69729156T DE69729156T DE69729156D1 DE 69729156 D1 DE69729156 D1 DE 69729156D1 DE 69729156 T DE69729156 T DE 69729156T DE 69729156 T DE69729156 T DE 69729156T DE 69729156 D1 DE69729156 D1 DE 69729156D1
Authority
DE
Germany
Prior art keywords
fpsa
antibody
cpsa
specific
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69729156T
Other languages
English (en)
Other versions
DE69729156T2 (de
Inventor
William Jeffrey Allard
Kwok K Yeung
Zeqi Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69729156(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/903,750 external-priority patent/US5840501A/en
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of DE69729156D1 publication Critical patent/DE69729156D1/de
Application granted granted Critical
Publication of DE69729156T2 publication Critical patent/DE69729156T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
DE69729156T 1996-10-25 1997-10-13 Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA) Expired - Lifetime DE69729156T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US73838396A 1996-10-25 1996-10-25
US738383 1996-10-25
US83496997A 1997-04-07 1997-04-07
US834969 1997-04-07
US08/903,750 US5840501A (en) 1996-10-25 1997-07-31 Determination of cPSA
US903750 1997-07-31

Publications (2)

Publication Number Publication Date
DE69729156D1 true DE69729156D1 (de) 2004-06-24
DE69729156T2 DE69729156T2 (de) 2005-05-25

Family

ID=27419236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729156T Expired - Lifetime DE69729156T2 (de) 1996-10-25 1997-10-13 Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA)

Country Status (14)

Country Link
US (2) US6107049A (de)
EP (1) EP0838680B1 (de)
JP (1) JP4274330B2 (de)
AT (1) ATE267399T1 (de)
AU (1) AU746345B2 (de)
CA (1) CA2214488C (de)
CZ (1) CZ295854B6 (de)
DE (1) DE69729156T2 (de)
DK (1) DK0838680T3 (de)
ES (1) ES2221006T3 (de)
HU (1) HU221350B1 (de)
IL (1) IL121659A (de)
NO (1) NO974534L (de)
PT (1) PT838680E (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19641560A1 (de) * 1996-10-09 1998-04-16 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
WO1999033878A1 (fr) * 1997-12-25 1999-07-08 Japan Tobacco Inc. Anticorps monoclonal contre le facteur de croissance du tissu conjonctif et ses mises en applications medicales
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
CA2311512A1 (en) * 1999-07-24 2001-01-24 Bayer Corporation Reflex method for the detection of prostate cancer
JP3536731B2 (ja) * 1999-07-28 2004-06-14 富士レビオ株式会社 ＨＩＶ−１ｐ２４抗原の免疫測定方法及び試薬
US6569684B2 (en) 2000-01-06 2003-05-27 University Of Central Florida Method of identifying and treating invasive carcinomas
US6379550B1 (en) 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel
DE60107022T2 (de) 2000-07-24 2005-11-24 Health Research Inc. Verfahren zur Detektion von Prostata-spezifischem Membran-Antigen in Serum
AU8475301A (en) * 2000-08-07 2002-02-18 Univ Vanderbilt Detection of cox-2 activity and anandamide metabolites
EP1320753A2 (de) * 2000-09-25 2003-06-25 Abbott Laboratories Verfahren und kits zur reduzierung von störungen in plasma oder serum enthaltenden proben bei spezifische bindungstests unter verwendung eines grossen polycations
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
EP1506407B1 (de) * 2002-03-13 2006-06-28 Biomerieux Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
US7666981B1 (en) 2002-05-10 2010-02-23 University Of Central Florida Research Foundation, Inc. Inhibitors of prostasin
US7314709B2 (en) * 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
CN1934449A (zh) * 2004-01-28 2007-03-21 图尔库大学 用于诊断急性冠状动脉综合征的改进的方法
US8012694B2 (en) 2006-09-14 2011-09-06 Immutopics, Inc. Assay for the detection of phosphorylated PTH
EP2107377A1 (de) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-Endothelin-1-Spiegel für die Risikobestimmung von tachyarrhthmischen Ereignissen
CN107402307A (zh) * 2008-04-09 2017-11-28 B.R.A.H.M.S 有限公司 用于预测受损峰值耗氧量的内皮素1原
US8658164B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8658166B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US20130116131A1 (en) 2011-11-08 2013-05-09 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8632971B2 (en) 2011-11-08 2014-01-21 Caldera Health Limited Methods and materials for determining the efficacy of prostate cancer therapies
JP6604081B2 (ja) * 2014-08-13 2019-11-13 東ソー株式会社 Ｎ型糖鎖が付加している膵臓リボヌクレアーゼ１の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0690203B2 (ja) * 1985-08-23 1994-11-14 中外製薬株式会社 前立腺特異抗原とα▲下１▼−アンチトリプシン複合体の定量方法
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
EP0635575A1 (de) * 1993-07-22 1995-01-25 Wallac Oy Monoklonale Antikörper gegen Epitope in freiem uber nicht in Alpha-1-antichymotrypsin komplexiertem Prostata spezifisches Antigen
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5698402A (en) * 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5710007A (en) * 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
CA2214488C (en) 2007-06-19
IL121659A (en) 2000-07-16
JP4274330B2 (ja) 2009-06-03
EP0838680B1 (de) 2004-05-19
CA2214488A1 (en) 1998-04-25
US6107049A (en) 2000-08-22
CZ335797A3 (cs) 1998-05-13
HUP9701717A3 (en) 2000-04-28
HU9701717D0 (en) 1997-12-29
NO974534L (no) 1998-04-27
ATE267399T1 (de) 2004-06-15
AU3926797A (en) 1998-04-30
CZ295854B6 (cs) 2005-11-16
PT838680E (pt) 2004-08-31
DE69729156T2 (de) 2005-05-25
HUP9701717A2 (hu) 1998-05-28
ES2221006T3 (es) 2004-12-16
HU221350B1 (en) 2002-09-28
US5928878A (en) 1999-07-27
IL121659A0 (en) 1998-02-22
AU746345B2 (en) 2002-04-18
EP0838680A1 (de) 1998-04-29
NO974534D0 (no) 1997-10-01
JPH10177027A (ja) 1998-06-30
DK0838680T3 (da) 2004-09-27

Similar Documents

Publication Publication Date Title
DE69729156D1 (de) Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA)
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
CY1115366T1 (el) Δεικτες ογκου
ATE328278T1 (de) Sammelapparat für einschrittigen test von mundflüssigkeiten
RU2003133925A (ru) Способ дифференциальной диагностики деменции альцгеймера и устройство для его проведения
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
KR20110069618A (ko) 전립선암 진단용 키트 및 진단방법
DE3780480T2 (de) Test fuer menschlichen brustkrebs.
US5994085A (en) Methods and devices for detecting non-complexed prostate specific antigen
NZ335535A (en) Immunohistochemical assay for carcinoma proliferative status by detecting presence of NGAL protein
DE69811157T2 (de) Immunoassay zur Bestimmung von PSA-ACT
DK1200826T3 (da) Immunoassay og testanordning med integreret reference
JP2005524380A (ja) 敗血症状態の発症および存在を決定するための装置及び方法
Christofidis Scientific background of the project [Radioimmunometric assay for Prostate Specific Antigen (PSA) measurement]
FI104219B1 (fi) Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi
ATE208041T1 (de) A-protein als diagnostikum für krebs
ITMI962054A1 (it) Saggio per la determinazione di anticorpi anti-endomisio
EP1072890A2 (de) Verfahren zum Nachweis von Prostatakrebs
KR20080040306A (ko) 현장검사용 암 진단 시스템

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC. (N.D.GES.D, US

8328 Change in the person/name/address of the agent

Representative=s name: MAIER, D., DIPL.-ING. UNIV., PAT.-ASS., 81739 MUEN